1. Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review

   • Juntaro Matsuzaki
   • Takahiro Ochiya

   Invited Review Article 27 February 2017 Pages: 413 - 420

   

2. Circulating tumor cells: clinical validity and utility

   • Luc Cabel
   • Charlotte Proudhon
   • François-Clément Bidard

   Invited Review Article 25 February 2017 Pages: 421 - 430

   

3. Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma

   • Go Omura
   • Mizuo Ando
   • Tatsuya Yamasoba

   Original Article 02 January 2017 Pages: 431 - 437

   

4. Extent of thyroid resection and thyroid function after postoperative radiotherapy following total laryngectomy or total pharyngo-laryngo-esophagectomy

   • Rio Kojima
   • Kiyoaki Tsukahara
   • Yasuo Ogawa

   Original Article 04 January 2017 Pages: 438 - 441

5. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer

   • Torahiko Nakashima
   • Ryuji Yasumatsu
   • Takashi Nakagawa

   Original Article 06 January 2017 Pages: 442 - 447

   

6. Multivariate evaluation of Thyroid Imaging Reporting and Data System (TI-RADS) in diagnosis malignant thyroid nodule: application to PCA and PLS-DA analysis

   • Tan Zhang
   • Fangxuan Li
   • Sheng Zhang

   Original Article 20 February 2017 Pages: 448 - 454

   

7. Retrospective analysis of lung cancer patients treated with supportive care alone

   • Hironori Ashinuma
   • Masato Shingyoji
   • Ikuo Sekine

   Original Article 31 January 2017 Pages: 455 - 460

   

8. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma

   • Takashi Suzuki
   • Hideaki Shimada
   • Hironori Kaneko

   Original Article 07 January 2017 Pages: 461 - 468

   

9. Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer

   • Kenichi Nakamura
   • Naoya Yoshida
   • Hideo Baba

   Original Article 17 January 2017 Pages: 469 - 475

   

10. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer

    • Toru Aoyama
    • Tsutomu Sato
    • Takaki Yoshikawa

    Original Article 07 February 2017 Pages: 476 - 483

    

11. Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy

    • Chih-Ching Yeh
    • Ching-Yu Lai
    • Yi-Kuei Lin

    Original Article 02 January 2017 Pages: 484 - 493

    

12. Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

    • Takeshi Suto
    • Megumi Ishiguro
    • Naohiro Tomita

    Original Article Open access 11 January 2017 Pages: 494 - 504

    

13. Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan

    • Kazuhito Minami
    • Masaru Morita
    • Kyushu Study Group of Clinical Cancer (KSCC)

    Original Article 18 January 2017 Pages: 505 - 510

    

14. Preoperative platelet–lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    • Tiffany Sin Hui Bong
    • Grace Hwei Ching Tan
    • Melissa Ching Ching Teo

    Original Article 30 January 2017 Pages: 511 - 518

    

15. Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy

    • Toshiyuki Kitai
    • Kenya Yamanaka
    • Masahiro Kawashima

    Original Article 04 January 2017 Pages: 519 - 525

    

16. Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations

    • Tatsunori Miyata
    • Yo-ichi Yamashita
    • Hideo Baba

    Original Article 15 February 2017 Pages: 526 - 532

    

17. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer

    • Kei Tanaka
    • Yoichi Kobayashi
    • Mitsutoshi Iwashita

    Original Article 12 January 2017 Pages: 533 - 540

    

18. Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network Survey

    • Hideki Tokunaga
    • Fumiaki Takahashi
    • Yoh Watanabe

    Original Article 10 February 2017 Pages: 541 - 547

    

19. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis

    • Yusuke Tsuda
    • Tohru Nakagawa
    • Hirotaka Kawano

    Original Article 02 January 2017 Pages: 548 - 553

    

20. Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy

    • Masashi Matsushima
    • Eiji Kikuchi
    • Masahiro Jinzaki

    Original Article 10 February 2017 Pages: 554 - 562

    

21. Effect of intraoperative radiotherapy in the treatment of retroperitoneal sarcoma

    • Liz B. Wang
    • David McAneny
    • Teviah Sachs

    Original Article 10 January 2017 Pages: 563 - 568

    

22. Review and proposal of regional surgical management for melanoma: revisiting of integumentectomy and incontinuity dissection in treatment of skin melanoma

    • Toshihiko Hayashi
    • Hiroshi Furukawa
    • Yuhei Yamamoto

    Original Article 07 January 2017 Pages: 569 - 576

    

23. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population

    • Yoshitsugu Shibayama
    • Kenjiro Namikawa
    • Naoya Yamazaki

    Original Article 31 January 2017 Pages: 577 - 584

    

24. Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma

    • Kai Ding
    • Xiaoshuang Chen
    • Rong Fu

    Original Article 16 February 2017 Pages: 585 - 592

    

25. Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions

    • Yuki Kawarada
    • Masayuki Miyazaki
    • Kiyofumi Yamada

    Original Article 25 January 2017 Pages: 593 - 599

    

26. Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy

    • Takako Inoue
    • Madoka Kimura
    • Fumio Imamura

    Original Article 31 January 2017 Pages: 600 - 604

    

27. Febuxostat and tumor lysis syndrome: an indication that remains unclear

    • F. Vincent
    • A. Dupré
    • M. Darmon

    Letter to the Editor 01 December 2016 Pages: 605 - 606

28. Reply to comments from Vincent et al.

    • Kazuo Tamura

    Letter to the Editor 02 February 2017 Pages: 607 - 608